GIM
PLSE icon

Granahan Investment Management’s Pulse Biosciences PLSE Stock Holding History

Granahan Investment Management’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-435,160
Closed -$6.45M – 189
2021
Q4 		$6.45M Buy
435,160
+69,395
+19% +$1.38M 0.13% 137
2021
Q3 		$7.9M Buy
+365,765
New +$7.87M 0.15% 128

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Granahan Investment Management's PLSE Position: Q1 2022 in Review

Granahan Investment Management sold out of Pulse Biosciences (PLSE) in Q1 2022, closing a stake of 435,160 shares — an estimated $6.45M sold.

Granahan Investment Management first reported a position in PLSE in Q3 2021 and held it in 2 quarters. The position peaked at $7.9M in Q3 2021. 55 funds tracked by Wall St. Rank hold PLSE as of Q1 2022.

  • Granahan Investment Management reported no remaining Pulse Biosciences position as of Q1 2022 after selling out during the quarter.
  • Granahan Investment Management sold 435,160 Pulse Biosciences shares in Q1 2022, an estimated $6.45M.
  • Granahan Investment Management first reported a position in Pulse Biosciences in Q3 2021 and held it in 2 quarters.
  • Granahan Investment Management's Pulse Biosciences position peaked at $7.9M in Q3 2021.
  • 55 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2022.

Based on Granahan Investment Management's 13F filing for Q1 2022, filed 16 May 2022.